Cannabigerolic acid (CBGA) is a key precursor in the biosynthesis of various cannabinoids found in cannabis plants. It is produced from olivetolic acid and geranyl pyrophosphate through enzymatic reactions. CBGA serves as the starting point for the synthesis of three major cannabinoid lines: tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), and cannabichromenic acid (CBCA).

Understanding the chemistry and pharmacology of CBGA is crucial not only for unraveling the biosynthesis of cannabinoids in cannabis plants but also for exploring the therapeutic potential of these compounds. Ongoing scientific investigations continue to shed light on the diverse properties and potential medical benefits of CBGA and its role in the synthesis of other cannabinoids. CBGA itself has shown potential therapeutic properties. It has been investigated for its anti-inflammatory, antibacterial, and neuroprotective effects. Moreover, CBGA may have analgesic properties, suggesting it could be explored as a potential treatment for pain management. However, further research is needed to fully understand its pharmacological mechanisms and potential applications.